NovaPeptideRetatrutide
Ordered Retatrutide from NovaPeptide? Mail in a sample (US only) and let us test it for free.
Test my supplyNovaPeptide's retatrutide profile is low-concern under purity-focus scoring, with repeated 99.9% purity, identity passes, and fills from -12% to -1%. The main caveat is thin batch documentation, so the clean streak is evidence-limited.
Two sister domains tell conflicting China-manufacturer and Delaware-biotech stories, while registry and WHOIS records point elsewhere. The report traces the virtual-office address, informal payment rails, and copycat coupon-page confusion buyers must verify.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including NovaPeptide rows.
Cancel anytime
About NovaPeptide test results from Finnrick
NovaPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 3 peptides and 12 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible NovaPeptide peptides in this dataset are BPC-157 (2 tests), Retatrutide (9 tests) and Tesamorelin (1 test). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 12 recent tests.
Ordered Retatrutide from NovaPeptide? Mail in a sample (US only) and let us test it for free.
Test my supply